How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

AI-designed enzymes to produce therapeutics for global health

calendar_today November 11, 2026 domain university-of-manchester

Manchester researchers are combining enzyme engineering and AI to develop new biocatalytic manufacturing routes to important medicines. Supported by the Gates Foundation, the team has targeted lenacapavir, a long-acting HIV prevention drug. Using directed evolution, researchers evaluated more than 12,000 enzyme variants, producing an enzyme that achieved more than 98% substrate conversion, 90% isolated yield and 99.5% enantiomeric purity.

open_in_new Read original post